HighVista Strategies’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-38,566
Closed -$490K 167
2024
Q3
$490K Buy
+38,566
New +$490K 0.17% 131